Mosquito-borne diseases represent one of the world's most significant health threats. Every year, over 700 million people are infected with viruses or parasites carried by these insects, resulting in more than one million deaths according to the World Health Organization (WHO). In mainland France, the spread of the tiger mosquito (Aedes albopictus) is completely reshaping the situation: now established in over 78 departments in 2024, this vector enables the local transmission of dengue, chikungunya, and Zika on metropolitan soil. At Garden Reclaimer, specialists in eco-friendly mosquito traps, we see firsthand every day how urgent it is to understand these mechanisms in order to better protect ourselves.

What is an arbovirus and why are mosquitoes such effective vectors?

Arboviral diseases refer to all illnesses caused by arboviruses (short for arthropod-borne viruses), meaning viruses transmitted by blood-feeding arthropods such as mosquitoes, ticks, or sandflies. This transmission mechanism turns the mosquito into an exceptionally efficient biological vector, as the virus actively replicates within its body before being injected into the human host during a bite.

In practical terms, here is why a mosquito is such a dangerous vector:

  • Silent bite: the insect injects its anesthetic saliva, which delays detection of the bite and reduces the defensive reaction.
  • Internal viral replication: after biting an infected person, the mosquito digests the blood and the virus colonizes its salivary glands within 8 to 12 days (extrinsic incubation period).
  • Multiple transmission: a single individual can bite several people during one interrupted blood meal, thereby multiplying the risks of infection.
  • Climatic adaptability: vector mosquito species adapt to urban and peri-urban areas, where human density is highest.

Arboviruses now represent a major global public health concern. Dengue alone affects between 100 and 400 million people each year, according to WHO data (2023), and climate change is accelerating the geographic spread of mosquito vectors into latitudes that were previously spared.

arbovirus-transmission-moustique-humain

Dengue, Zika, chikungunya: what are the main diseases transmitted by Aedes mosquitoes?

Mosquito-borne diseases transmitted by the genus Aedes encompass three major arboviruses whose symptoms are very similar, frequently leading to misdiagnoses. Dengue, Zika, and chikungunya share the same primary vector—the tiger mosquito Aedes albopictus and Aedes aegypti—and often circulate across the same geographic areas.

Dengue: the most widespread arbovirus in the world

Dengue is caused by the dengue virus (DENV), which exists in four distinct serotypes. Symptoms include high fever (often exceeding 39°C), severe headaches, intense muscle and joint pain, and a skin rash (cutaneous exanthema). In its severe form, dengue can cause internal hemorrhaging, with a fatality rate that can reach up to 5% without proper medical care.

  • Incubation: 4 to 10 days after the bite.
  • Duration: symptoms generally appear and persist for 5 to 7 days.
  • Specificity: there is no direct antiviral treatment; management is symptomatic.

Chikungunya: joint pain as a clinical signature

Chikungunya is a virus whose name, derived from Swahili, literally means "that which bends up," referring to the debilitating joint pain it causes. Symptoms can last from several weeks to several months, with episodes of chronic polyarthralgia that leave patients with long-term disabilities. The symptoms of chikungunya are often initially mistaken for those of Zika or dengue.

  • Muscle pain: present within the first 48 hours.
  • Fever: sudden, often exceeding 38.5°C.
  • Skin rash: present in approximately 50% of cases.
douleurs articulaires symptômes de  a chikungunya

Zika: a major teratogenic risk for pregnant women

Zika is a particularly concerning virus due to its severe neurological complications. People infected with the Zika virus are often asymptomatic (in about 80% of cases), but in pregnant women, the virus can lead to fetal microcephaly—a serious brain malformation in newborns. The 2015–2016 epidemic in Brazil highlighted this threat, with over 2,600 confirmed cases of microcephaly.

  • Transmission: bite from a mosquito infected with the Zika virus, but also sexual transmission.
  • Symptoms: mild fever, skin rash, conjunctivitis, muscle pain.
  • Neurological risk: Guillain-Barré syndrome possible in adults.

Comparison of the main mosquito-borne arboviruses:

Comparatif des principales arboviroses transmises par les moustiques
Maladie Vecteur principal Symptômes clés Gravité Présence France hex.
Dengue Aedes aegypti / Ae. albopictus Fièvre, maux de tête, douleurs musculaires, hémorragie (forme sévère) Élevée —

Sources : Santé publique France, ECDC, ARS (2024).

How does a mosquito transmit a virus to humans? The vector mechanism explained

Understanding how a mosquito can transmit a virus is essential for grasping the real risks of mosquito bites. Transmission does not occur mechanically like a contaminated syringe: it involves a specific biological cycle within the insect's own body.

Here are the four stages of the vector transmission cycle:

  • Infectious blood meal: the female mosquito bites an infected person (or a reservoir animal) and ingests blood containing the virus or parasites.
  • Extrinsic incubation: the pathogen replicates in the mosquito's gut and then migrates to its salivary glands. This phase lasts 8 to 14 days depending on the ambient temperature.
  • Transmission bite: during a new blood meal, the infected mosquito injects its saliva, which now contains the pathogen in sufficient quantity to infect the human host.
  • Intrinsic incubation: in humans, symptoms generally appear between 4 and 14 days after the bite, depending on the transmitted virus.

However, a mosquito cannot transmit a virus through simple physical contact or its droppings. Only a bite serves as the vector for transmission. As a result, preventing bites remains the most effective form of protection, even before considering any medical treatment.

Malaria and yellow fever: mosquito-borne diseases that still kill on a massive scale

Beyond arboviruses linked to the genus Aedes, other mosquito-borne diseases continue to devastate certain regions of the world. Malaria and yellow fever are the deadliest examples.

Malaria is not caused by a virus, but by parasites of the genus Plasmodium, transmitted by female mosquitoes of the genus Anopheles. In 2022, the WHO recorded 249 million cases of malaria worldwide, resulting in 608,000 deaths, mainly in sub-Saharan Africa. The vectors for this disease are not present in mainland France, but imported cases are frequent: more than 6,000 human cases are reported in France every year.

Yellow fever, for its part, is a potentially fatal arbovirus caused by a flavivirus, primarily transmitted by Aedes aegypti in tropical areas of Africa and South America. Its symptoms—high fever, jaundice, and bleeding—can be fatal in 20% to 50% of severe untreated cases. Chikungunya and yellow fever thus fall into the same category of severe threats, even though their vectors and areas of circulation differ.

  • Malaria prevention: medication-based chemoprophylaxis and physical repellents.
  • Yellow fever prevention: mandatory vaccination for certain trips to endemic areas.
  • Common protection: long clothing, approved repellents, treated mosquito nets.
maladie meurtrière transmise par un moustique

West Nile Virus: an emerging arboviral disease in mainland France

When it comes to monitoring vector-borne diseases on French soil, West Nile virus has played an increasingly prominent role for several years. Transmitted by mosquitoes of the genus Culex (especially Culex pipiens, a very common species in France), this virus circulates between migratory birds and mosquitoes, with humans serving as accidental hosts.

In concrete terms, in mainland France, the first locally acquired human cases of West Nile virus were detected as early as 2015 in the Var department, followed by numerous confirmed cases across the Mediterranean basin. In 80% of cases, the infection is asymptomatic. However, in about 1% of cases, the virus causes potentially life-threatening encephalitis or meningitis, particularly in elderly and immunocompromised individuals.

  • Vector mosquitoes: primarily Culex pipiens. Animal reservoir: migratory birds (corvids, birds of prey). Symptoms (symptomatic form): fever, headache, rash, intense fatigue. Surveillance: the surveillance system relies on detection in birds, equids, and humans via doctors and laboratories partnering with Santé publique France.

Vector-borne disease surveillance in France: how do health authorities track arbovirus cases?

Disease surveillance for vector-borne infections in France is structured around a multi-tiered monitoring system coordinated by Santé publique France, in collaboration with Regional Health Agencies (ARS) and the national entomological network. This system incorporates both entomological surveillance (tracking mosquito populations and their geographic spread) and human epidemiological surveillance.

Case reporting rests on two primary pillars:

  • Notifiable diseases: dengue, chikungunya, malaria, and Zika are among the notifiable diseases. Doctors and laboratories are required to report any confirmed case to health authorities. Reporting imported and indigenous cases: every summer, Santé publique France publishes a weekly report on arbovirus cases detected in France, distinguishing between imported cases (returning from travel) and local transmission.

In 2023, more than 130 autochthonous cases of dengue were recorded in mainland France, marking a sharp increase compared to previous years. These figures highlight the risk of a local epidemic developing, especially during the tiger mosquito's peak activity period from May to November.

The World Mosquito Program and other international initiatives are also developing innovative biological strategies (such as releasing mosquitoes carrying the Wolbachia bacteria) to reduce the risk of large-scale arbovirus transmission.

Arbovirus surveillance system in France

Dispositif de surveillance des arboviroses en France hexagonale (2024)
Composante Acteurs Données collectées Fréquence
Surveillance entomologique EID Méditerranée, ARS, collectivités Densité et implantation du moustique tigre ; cartes de répartition Hebdomadaire (mai-nov.)
Déclaration obligatoire (MDO) Médecins, laboratoires, hôpitaux Cas confirmés de dengue, chikungunya, Zika, paludisme Immédiate dès diagnostic
Surveillance humaine Santé publique France, réseau Sentinelles Cas autochtones, cas importés, clusters Bulletin hebdomadaire
Surveillance animale ANSES, vétérinaires, LNR Oiseaux, équidés (West Nile Virus), rongeurs Continue
Communication publique ARS, mairies, Santé publique France Alertes épidémiques, conseils de prévention des maladies En temps réel si alerte

Sources : Santé publique France, ECDC, ARS (2024).

What concrete measures can be taken to protect against mosquito-borne diseases?

Preventing vector-borne diseases comes down to a simple principle that cannot be repeated often enough: avoiding bites is the first line of defense, well ahead of any treatment. In mainland France, where the tiger mosquito is active from May to November, control measures must be implemented on three levels: individual, household, and community.

On an individual level:

  • Skin repellents: products containing IR3535, DEET, or Picaridin are approved by ANSES and are the most reliable ways to avoid bites. Long clothing: covering arms and legs during the mosquito's active period significantly reduces exposure to bites. Mosquito nets: essential at night, especially for infants and pregnant women.

At the household level, mosquito control begins with reducing the risk of proliferation by eliminating breeding sites: any standing water in a plant saucer, bucket, or gutter represents a potential egg-laying site for the Aedes albopictus mosquito.

This is precisely the rationale behind our anti-mosquito traps: eco-friendly devices designed to protect gardens and patios against mosquito-borne diseases, without resorting to harsh chemicals. Effective mosquito control relies on prevention that is continuous and tailored to each home's surroundings.

Is climate change accelerating the spread of mosquito-borne diseases in Europe?

This issue is currently at the heart of research conducted by the European Centre for Disease Prevention and Control (ECDC). The conclusion is clear: climate change is actively expanding the transmission zones of mosquito-borne diseases by creating favourable conditions for new mosquito species to settle in historically unaffected regions.

Rising average temperatures prolong the mosquito activity season and accelerate viral replication within the insects (shortening the extrinsic incubation period). As a result, regions where the tiger mosquito was absent twenty years ago—including northern France, Belgium, and Germany—are now seeing this vector gradually establish itself.

In addition, increased heavy rainfall creates more breeding sites in urban environments. Arboviruses, once confined to the tropics, are now approaching our climatic borders. This reality calls for heightened disease surveillance and adapted control measures across Europe.

  • Dengue in Europe: 130 indigenous cases in France in 2023; cases also reported in Italy and Spain. West Nile Virus: expansion toward northern Europe, with human cases detected in Germany and Austria. Arbovirus control: ECDC experts recommend strengthening entomological surveillance and preventive mosquito control plans in at-risk cities.

FAQ — Frequently asked questions about mosquito-borne diseases

What are the most dangerous mosquito-borne diseases?

The world's most dangerous mosquito-borne diseases are malaria, severe dengue, yellow fever, and West Nile virus encephalitis. Malaria remains the deadliest, with 608,000 deaths recorded in 2022 according to the WHO, primarily in sub-Saharan Africa. In mainland France, dengue represents the most tangible threat, with confirmed autochthonous cases every summer since 2010, driven by the tiger mosquito, which was established across 78 departments by 2024. Although absent from Europe, yellow fever poses a serious risk to travellers visiting endemic areas in Africa and South America, with a case fatality rate that can exceed 50% in severe, untreated cases. The severity of each disease depends on the specific virus involved, the patient's health profile, and how quickly medical care is administered.

Can the tiger mosquito really transmit dengue in France?

Yes, the tiger mosquito (Aedes albopictus) can transmit dengue in mainland France and has already been documented doing so. For local transmission to occur, three conditions must be met: the presence of the tiger mosquito in the area, the presence of an infected individual (often returning from abroad), and temperatures warm enough to allow the virus to replicate within the mosquito. In 2023, Santé publique France recorded more than 130 locally acquired dengue cases in metropolitan France, mainly in the south. These cases demonstrate that the local transmission of dengue is no longer merely a theoretical risk. The danger grows each year as the tiger mosquito expands its range northward, making both individual and collective disease prevention more urgent than ever.

How can you distinguish between the symptoms of dengue, chikungunya, and Zika?

Distinguishing between these three arboviruses is challenging because their early symptoms are similar: fever, headaches, a skin rash, and fatigue. However, certain signs help guide a diagnosis. Chikungunya is characterised by particularly intense and persistent joint pain, which can often be debilitating for several weeks. Dengue is marked by severe bone and muscle pain, and it can progress to a severe haemorrhagic form accompanied by warning signs (abdominal pain, bleeding, rapid drop in platelet count). Zika, on the other hand, is often asymptomatic or causes only mild symptoms in adults, but its greatest danger lies in the potential harm to the foetus if contracted during pregnancy. If any symptoms develop within 15 days of a mosquito bite in an at-risk area, prompt medical attention is essential to prevent misdiagnoses and begin appropriate monitoring.

What are the most effective ways to avoid mosquito bites?

Preventing mosquito bites requires a combination of personal protection and environmental control. In terms of prevention, the most effective methods validated by health authorities include applying skin repellents containing DEET (20–50%), IR3535, or Picaridin to exposed areas, as well as wearing loose-fitting, light-coloured, long clothing during peak mosquito activity periods. At home, it is crucial to eliminate any standing water within seven days of rainfall, as these are the primary breeding grounds where the tiger mosquito lays its eggs. Insecticide-treated bed nets remain the gold standard for protecting young children and pregnant women overnight. Finally, perimeter mosquito control systems, such as the anti-mosquito traps offered by Garden Reclaimer, provide an effective complementary solution to safeguard outdoor living spaces without relying on broadcast chemical treatments.

Which mosquito-borne viruses are being monitored in France in 2025?

In 2025, vector-borne disease surveillance in France focuses primarily on five pathogens: dengue, chikungunya, Zika, West Nile virus, and Toscana virus (transmitted by sandflies, but tracked under the same monitoring system). These are classified as notifiable diseases, meaning that physicians and diagnostic laboratories must immediately report any confirmed case to the relevant Regional Health Agency (ARS). Case reporting feeds into a weekly epidemiological bulletin published by Santé publique France throughout the tiger mosquito's active season. The surveillance system also includes continuous entomological monitoring, with updated tiger mosquito distribution maps available on the signalement-moustique.fr platform. This integrated monitoring network allows for the rapid detection of any emerging local transmission and triggers the deployment of targeted control measures.

Do all mosquitoes transmit diseases?

No, not all mosquitoes transmit diseases, which is a key distinction when assessing actual risk. Out of the 3,500 documented mosquito species worldwide, only a few dozen serve as vectors for these diseases in humans. In France, the primary species to monitor are Aedes albopictus (the tiger mosquito) for dengue, chikungunya, and Zika, and Culex pipiens for West Nile virus. Mosquitoes of the genus Anopheles, which transmit malaria, are not present in mainland France under conditions that would support local transmission. Nevertheless, even non-vector species can cause allergic reactions, secondary bacterial skin infections at bite sites, and significant discomfort. Effective mosquito control therefore remains essential even outside epidemic risk zones, ensuring everyday outdoor comfort and quality of life.

Conclusion: act now to protect yourself from mosquito-borne diseases

Mosquito-borne diseases are no longer a distant concern reserved for tropical travellers. The spread of the tiger mosquito across mainland France, coupled with the effects of climate change, has brought these health risks directly into our summer routines. Understanding the vector's role, recognising early symptoms, and adopting practical preventive measures form the three cornerstones of an effective response.

At Garden Reclaimer, we have designed a line of eco-friendly mosquito traps engineered to protect gardens, patios, and outdoor living areas without harming the environment. Explore our solutions at garden-reclaimer.com and take action before the start of the next mosquito season.

‍

Take action: book your rental trial

Request a study: diagnostic to estimate the ideal coverage based on your floor plans or map study. Eligible for the 2026 rental program.

Book a trial
GRéco unit installed discreetly on a wooden deck by a swimming pool, with a modern villa in the background.

Take action: book your rental trial

Request a study: diagnostic to estimate the ideal coverage based on your floor plans or map study. Eligible for the 2026 rental program.

Book a trial
GRéco unit installed discreetly on a wooden deck by a swimming pool, with a modern villa in the background.